16 research outputs found

    Addition of docetaxel to hormonal therapy in low- and high-burden metastatic hormone sensitive prostate cancer : long-term survival results from the STAMPEDE trial

    Get PDF
    Background STAMPEDE has previously reported that the use of upfront docetaxel improved overall survival (OS) for metastatic hormone naïve prostate cancer patients starting long-term androgen deprivation therapy. We report on long-term outcomes stratified by metastatic burden for M1 patients. Methods We randomly allocated patients in 2 : 1 ratio to standard-of-care (SOC; control group) or SOC + docetaxel. Metastatic disease burden was categorised using retrospectively-collected baseline staging scans where available. Analysis used Cox regression models, adjusted for stratification factors, with emphasis on restricted mean survival time where hazards were non-proportional. Results Between 05 October 2005 and 31 March 2013, 1086 M1 patients were randomised to receive SOC (n = 724) or SOC + docetaxel (n = 362). Metastatic burden was assessable for 830/1086 (76%) patients; 362 (44%) had low and 468 (56%) high metastatic burden. Median follow-up was 78.2 months. There were 494 deaths on SOC (41% more than the previous report). There was good evidence of benefit of docetaxel over SOC on OS (HR = 0.81, 95% CI 0.69–0.95, P = 0.009) with no evidence of heterogeneity of docetaxel effect between metastatic burden sub-groups (interaction P = 0.827). Analysis of other outcomes found evidence of benefit for docetaxel over SOC in failure-free survival (HR = 0.66, 95% CI 0.57–0.76, P  0.5 in each case). There was no evidence that docetaxel resulted in late toxicity compared with SOC: after 1 year, G3-5 toxicity was reported for 28% SOC and 27% docetaxel (in patients still on follow-up at 1 year without prior progression). Conclusions The clinically significant benefit in survival for upfront docetaxel persists at longer follow-up, with no evidence that benefit differed by metastatic burden. We advocate that upfront docetaxel is considered for metastatic hormone naïve prostate cancer patients regardless of metastatic burden

    Biofuels, greenhouse gases and climate change. A review

    Full text link

    High-voltage (1.8V) tandem solar cell system using a GaAs/AlXGa(1−X)As graded solar cell and dye-sensitised solar cells with organic dyes having different absorption spectra

    No full text
    Stacked multijunction (tandem) solar cells have been prepared by mechanically stacking dye-sensitised solar cells (DSCs) and a GaAs/AlXGa(1−X)As graded solar cell (GGC) as the top and bottom cells, respectively. Three organic dyes with different absorption spectra (D131, D102 and D205) were used in the DSCs, in order to match the photocurrent density between the DSC and the GGC. Tuning the absorption range of the DSC by choosing an appropriate dye, increased the overall photovoltaic conversion efficiency due to the optimal utilisation of the solar spectrum in the individual cells. The open circuit photovoltages (VOC) of the GGC and the DSC with D131 were 1.11 V and 0.76 V, respectively, resulting in a VOC of 1.85 V and a photovoltaic conversion efficiency of 7.63% for the tandem cell. Although the overall conversion efficiency has not exceeded that of the GGC (7.66%), these tandem cells provide adequate VOC values for water splitting applications

    Recommendations for locus-specific databases and their curation.

    Get PDF
    Expert curation and complete collection of mutations in genes that affect human health is essential for proper genetic healthcare and research. Expert curation is given by the curators of gene-specific mutation databases or locus-specific databases (LSDBs). While there are over 700 such databases, they vary in their content, completeness, time available for curation, and the expertise of the curator. Curation and LSDBs have been discussed, written about, and protocols have been provided for over 10 years, but there have been no formal recommendations for the ideal form of these entities. This work initiates a discussion on this topic to assist future efforts in human genetics. Further discussion is welcome

    Iron speciation in minerals and glasses probed by M2/3-edge X-ray Raman scattering spectroscopy

    No full text
    We present a spectroscopic study of the iron M2/3-edge for several minerals and compounds to reveal information about the oxidation state and the local coordination of iron. We describe a novel approach to probe the iron M2/3-edge bulk sensitively using X-ray Raman scattering. Significant changes in the onset and shape of the Fe M2/3-edge were observed on ferrous and ferric model compounds with Fe in octahedral and tetrahedral coordination. Simulation of the spectra is possible using an atomic multiplet code, which potentially allows determination of, e.g., crystal-field parameters in a quantitative manner. A protocol is discussed for determination of the Fe oxidation state in compounds by linear combination of spectra of ferric and ferrous end members. The presented results demonstrate the capabilities of Fe M2/3-edge spectroscopy by X-ray Raman scattering to extract information on the ratio of trivalent to total iron Fe3+}/∑Fe and local coordination. As X-ray Raman scattering is performed with hard X-rays, this approach is suitable for in situ experiments at high pressure and temperature. It thus may provide indispensable information on oxidation state, electronic structure and local structure of materials that are important for physical and chemical processes of the deep Earth. © 2014 Springer-Verlag Berlin Heidelberg
    corecore